The development of a [211AT]-astatinated endoradiotherapeutic drug: Part IV - Late radiation effects

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 5, 1998, Pages 1177-1183

  Brown, Ian ^a   Mitchell, Joseph S ^a  

^a The Radiotherapeutic Ctr U   (United Kingdom)

Author keywords

211Astatine; Dosimetry; High LET; Pulmonary fibrosis; Targeted endoradiotherapy; Tumour induction

Indexed keywords

6 ASTATO 2 METHYL 1,4 NAPHTHOQUINOL DIPHOSPHATE AT 211; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ASTATINE;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG FIBROSIS; LYMPHOMA; MALE; MOUSE; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; RECTUM CARCINOMA; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG SCREENING; LUNG; MORTALITY; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; THYROID GLAND;

ANIMALS; ASTATINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG SCREENING ASSAYS, ANTITUMOR; LUNG; LYMPHOMA; MALE; MICE; MICE, INBRED C57BL; PLASMACYTOMA; RADIATION INJURIES, EXPERIMENTAL; RADIOPHARMACEUTICALS; THYROID GLAND;

EID: 0032520269     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00907-3     Document Type: Article

References (37)

1. Brown I. The development of potential endoradiotherapeutic drugs for malignant disease. Raynaud C. Nuclear medicine and biology. Vol. 1:1982;165-169 Pergamon Press, Paris.
2. 125I]-iodo-2-methyl-1,4-naphthoquinol bis(diammonium phosphate) as a potential radiohalogenated anti-cancer agent in vitro investigations and possible clinical implications . Eur. J. Nucl. Med. 7:1982;115-120.
3. 211At- in mice with a transplanted rectal adenocarcinoma. Int. J. Appl. Radiat. Isotopes. 35:1984;843-847.
4. Brown, I. High linear energy transfer endoradiotherapeutic drugs for malignant disease. M.D. Thesis, University of Cambridge, UK; 1987.
5. 211At]-astatinated endoradiotherapeutic drug Part I. Localization by α-particle autoradiography in a mouse tumor model . Int. J. Radiat. Oncol. Biol. Phys. 23:1992;563-572.
6. 211At]-astatinated endoradiotherapeutic drug Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice, and associated studies . Int. J. Radiat. Oncol. Biol. Phys. 30:1994;115-124.
7. 211At]-astatinated endoradiotherapeutic drug: Part III. Tissue dosimetry and its implications for human cancer therapy. Int. J. Radiat. Oncol. Biol. Phys. 1998 (in press).
8. Brown I. Astatine-211 its possible application in cancer therapy . Appl. Radiat. Isotopes. 37:(Part A):1986;789-798.
9. Franks L. M., Hemmings G. T. A cell line from an individual carcinoma of the mouse rectum. J. Path. 124:1978;35-38.
10. Smith G. S., Walford R. L., Mickey M. R. Life span and incidence of tumors and other diseases in selective long lived mice and their F1 hybrids. J. Natl. Cancer Inst. 50:1973;1195-1213.
11. Mitruka B. M., Rawnsley H. M. Clinical biochemical and haematological reference values in normal experimental animals. 1977;272-273 Masson Publishing, New York.
12. Mathé, G.; Rappaport, H.; O Conor, G. T.; Dorloni, H. Histological and cytological typing of neoplastic diseases of the hematopoietic and lymphoid tissues. In: WHO. International histological classification of tumors, No. 14. Geneva: World Health Organisation; 1976.
13. 211At]astatide in B6C3F1 and Balb/c (nu/nu) mice a long-term survival study with histological analysis . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;69-80.
14. Travis E. L. The sequence of histological changes in mouse lungs after a single dose of x-rays. Int. J. Radiat. Oncol. Biol. Phys. 6:1980;345-347.
15. Steel G. G., Adams K., Peckham M. J. Lung damage in C57Bl mice following thoracic irradiation. Enhancement by chemotherapy. Br. J. Radiol. 57:1979;741-747.
16. Perez C. A., Brady L. W. Overview. Perez C. A., Brady L. W. Principles and practice of radiation oncology. 1992;1-63 Lippincott, Philadelphia, London.
17. Cuzick J. Radiation-induced myelomatosis. N. Engl. J. Med. 104:1981;204-216.
18. 224Ra of myeloid leukaemia and osteosarcoma in male CBA mice. Int. J. Radiat. Biol. 47:1985;239-247.
19. Spiess H., Mays C. W. Bone cancers induced by 224-Ra (ThX) in children and adults. Health Phys. 19:1970;723-729.
20. Ueda G., Mori T. Astatine-211 induced transplantable pituitary tumor in the rat with a brief analytic review of cell types of pituitary tumor. Am. J. Pathol. 51:1967;601-620.
21. 224Ra-treated ankylosing spondylitis patients. IAEA. Biological effects of low-level radiation. 1983;281-283 International Atomic Energy Agency, Vienna.
22. Yokoro K., Kunii A., Furth J., Durbin P.W. Tumor induction with astatine-211 in rats characterization of pituitary tumors . Cancer Res. 24:1964;683-688.
23. Durbin P. W., Asling C. W., Johnston M. E., Parrott M. W., Jeung N., Williams M. H., Hamilton J. G. The induction of tumors in the rat by astatine-211. Radiat. Res. 9:1958;378-397.
24. Hamilton J. G., Asling C. W., Garrison W. M., Scott K. G. The accumulation, metabolism and biological effects of astatine in rats and monkeys. Univ. Calif. Publ. Pharmacol. 2:1953;283-344.
25. Hamilton J. G., Durbin P. W., Parrott M. W. The accumulation and destructive action of astatine-211 (eka-iodine) in the thyroid gland of rats and monkeys. J. Clin. Endocrinol. Metab. 14:1954;1161-1178.
26. Hamilton J. G., Durbin P. W., Parrott M. W. Comparison of acute and chronic changes produced in rats by iodine-131 and astatine-211 at lethal levels. Johnston J. E. Medical and physiological applications. Vol. 1:1954;219-231 Butterworth Scientific Publications, London.
27. 131. Proc. Soc. Exp. Biol. Med. 71:1949;237-240.
28. 90Y . Int. J. Radiat. Oncol. Biol. Phys. 10:1984;341-348.
29. Brown I., Randle K. Astatine-211 endogenous alpha-radiotherapy for thyroid cancer . Contrib. Oncol. 51:1996;161-166.
30. Pattengale P. K. Plasma cell tumours in mice. Turusov V., Mohr U. Pathology of tumours in laboratory animals. Vol. 2:1992;651-670 Interntional Agency for Research on Cancer Scientific Publications No. 111, Lyon.
31. Cottier H. Strahlenbedingte Lebenverkürzung. 1961;113-115 Springer-Verlag, Berlin, Göttingen, Heidelberg.
32. Rask-Nielsen R., Gormsen H. Spontaneous and induced plasma-cell neoplasia in a strain of mice. Cancer. 4:1951;387-397.
33. Van den Brenk H. A. S. Radiation effects on the pulmonary system. Berdjis C. C. Pathology of irradiation. 1971;569-591 Williams & Wilkins Company, Baltimore.
34. Down J. D., Steel G. G. The expression of early and late damage after thoracic irradiation a comparison between CBA and C57BL mice . Radiat. Res. 96:1983;603-610.
35. Siemann D. W., Hill R. P., Penney D. P. Early and late pulmonary toxicity in mice evaluated 180 and 420 days following localized lung irradiation. Radiat. Res. 89:1980;396-407.
36. Patrick G. Symposium report - the production of late damage in the lung. Int. J. Radiat. Biol. 46:1984;473-475.
37. Wunderlich G., Franke W-G., Hlics R, Doberenz W. Dosimetrische Betrachtungen nach Applikation von At-211-markierten Mikrosphären. Med. Nucl. 1:1990;25-27.